CD19 and acute lymphoblastic leukemia: Research teams from the University of Pennsylvania and Children's Hospital of Philadelphia initiated clinical trials investigating CTL019, an enhanced version of CD19 CAR-T therapy, for treating B-ALL patients [252, 253].